| Literature DB >> 33180262 |
Kensuke Yamamura1, Toru Beppu2, Nobutaka Sato1, Eri Oda1, Koichi Kinoshita1, Hideaki Yuki3, Toshihiko Motohara4, Hideaki Miyamoto5, Tsutomu Oda6, Shinichi Akahoshi1.
Abstract
Multidisciplinary treatment is recommended for the management of patients with advanced hepatocellular carcinoma (HCC). Some operative decollateralization of extrahepatic feeding arteries with laparotomy have been introduced for HCC. We herein newly develop laparoscopic devascularization (LDEV) to continue transarterial chemoembolization (TACE) for HCC with extrahepatic collateral arteries. A 74-year-old man with multiple huge HCC (4 tumors, 18 cm in diameter) and poor liver function (non-alcoholic steatohepatitis, Child-Pugh score 7) was treated with 6 times of chemoembolization in combination with LDEV, 3 times of ablation therapies, and lenvatinib therapy. His tumor markers were triple positive (AFP, 12,906.5 ng/ml; PIVKA-II, 491,743 mAU/ml; AFP-L3, 91.8%) before treatments; however, they all returned to normal limits. Complete response was achieved according to the modified RECIST criteria. Unfortunately, he died 6 months after the final treatment with no recurrence of HCC due to the postoperative complication of primary lung cancer. LDEV is a useful tool to continue effective TACE, and multidisciplinary treatment including chemoembolization and LDEV can cure advanced HCC patients with extrahepatic collaterals and impaired liver function.Entities:
Keywords: Case report; Extrahepatic collateral artery; Hepatocellular carcinoma; Laparoscopic devascularization; Transarterial chemoembolization
Mesh:
Year: 2020 PMID: 33180262 DOI: 10.1007/s12328-020-01286-2
Source DB: PubMed Journal: Clin J Gastroenterol ISSN: 1865-7265